The red-blood-cell-boosting hormone erythropoietin (EPO), which is used clinically to treat anemia and illegally by athletes to boost endurance, may also improve brainpower. According to research ...

More often then we’d like to admit, there are days when hitting the gym is the last thing we want to do. But now scientists say they’ve discovered a hormone that may actually motivate humans to ...

Sportsmen and women have been known to dope with the blood hormone Epo to enhance their performance. Researchers have now discovered, through animal testing, that Epo has a performance-enhancing ...

The increasingly common practice of using a synthetic form of the hormone EPO to maintain normal red blood cell levels in chronic kidney disease patients may increase cardiovascular risks, according ...

When three cyclists got caught using the banned drug EPO this month, they were forced to take an abrupt detour from the Tour de France -- and perhaps from their riding careers. Of course, even as some ...

A new study has found that a hormone often used to reduce the need for blood transfusions may also prevent brain injuries in premature babies. The erythropoietin (EPO) hormone, responsible for ...

Two things happen following a heart attack--necrosis (normal cell death) and apoptosis (programmed cell death) -- and both are bad. Now researchers in Japan have found that a single intravenous dose ...

COLORADO SPRINGS, Colo. — A drug that mimics EPO as a way to help patients with kidney problems is in the late stages of development, one in a long list of new pharmaceuticals that anti-doping ...

Since 1989, physicians have prescribed the hormone erythropoietin (EPO) to combat anemia from blood loss, kidney failure, and cancer treatments. This compound orchestrates red blood cell production.

Proceedings of the National Academy of Sciences of the United States of America, Vol. 96, No. 13 (Jun. 22, 1999), pp. 7569-7574 (6 pages) Applying a homology search method previously described, we ...

John A. Moran Eye Center researchers continue to shed new light on the potential of the hormone erythropoietin (EPO) to treat eye disease. EPO increases red blood cell production, and is already used ...